l9n/ North Dakota

2023 Regular Session, 2023–2024

Senate Bill 2384

Relating to vaccines for respiratory syncytial virus and vaccines developed using messenger ribonucleic acid technology.

Did not become law. It stopped in the House of Representatives on April 4, 2023. The 68th Legislative Assembly has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

A BILL for an Act to provide for a legislative management study relating to vaccines for respiratory syncytial virus and vaccines developed using messenger ribonucleic acid technology.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

3 co-sponsors

David A. Clemens, Scott Dyk, Jeff Hoverson

Its course

January 23 to April 4, 2023, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action13 actions on 9 days

In the SenateJan 23 to Feb 917 days

Human ServicesJan 23 to Feb 917 days

In the House of RepresentativesFeb 9 to Apr 4 · stopped54 days

Human ServicesFeb 17 to Apr 345 days

Votes

Yeas to nays, as the Legislative Assembly recorded them. Committee votes are set in.

Amendments

Each amendment offered, and what became of it.

  • Senate floor amendmentAdopted

    Adopted Feb 9

Text

Each version as the Legislative Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

In the Senate Jan 23 – Feb 9

  1. Introduced and sent to Human Services
  2. Heard in Human Services
  3. Heard in Human Services
  4. Human Services recommended against it, 6 to 0
  5. Amended on the floor
  6. Passed the Senate, 25 to 22

In the House of Representatives Feb 10 – Apr 4

  1. Arrived in the House of Representatives
  2. Read a first time and sent to Human Services
  3. Heard in Human Services
  4. Heard in Human Services
  5. Human Services recommended against it, 7 to 6
  6. Failed in the House of Representatives, 38 to 53
All 13 actions, as published